Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $109.1200 (1.13%) ($104.0000 - $109.1700) on Tue. Jan. 10, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.55% (three month average) | RSI | 50 | Latest Price | $109.1200(1.13%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SONN advances 0.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) IWN(17%) QQQ(17%) TBT(17%) XAR(17%) IWC(16%) | Factors Impacting SONN price | SONN will decline at least -2.775% in a week (0% probabilities). VCSH(-27%) LQD(-20%) TLT(-19%) VCIT(-15%) CEMB(-15%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.775% (StdDev 5.55%) | Hourly BBV | 0 () | Intraday Trend | 4.9% | | | |
|
1 - 5 Day Possible Target | $98.48(-9.75%) | Resistance Level | $111.76 | 5 Day Moving Average | $108.31(0.75%) | 10 Day Moving Average | $108.79(0.3%) | 20 Day Moving Average | $111.76(-2.36%) | To recent high | -25.1% | To recent low | 4.9% | Market Cap | $1.004b | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |